REVVITY, INC Income (Loss) from Continuing Operations before Income Taxes, Domestic
REVVITY, INC (RVTY) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of $142.63 million for the 12-month period ending 2025-12-28, per its 10-K filed 2026-02-24.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-02-24
- REVVITY, INC income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was $142.63M, a 6.30% increase from fiscal 2024.
- REVVITY, INC income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was $134.18M, a 161.48% increase from fiscal 2023.
- REVVITY, INC income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was $51.31M, a 84.28% decline from fiscal 2023.
- REVVITY, INC income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was $326.44M, a 40.40% decline from fiscal 2022.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month as first filed |
|---|---|---|
| 2025-12-28 | $142.63M 10-K · filed 2026-02-24 | |
| 2024-12-29 | $134.18M 10-K · filed 2026-02-24 | |
| 2023-12-31 | $51.31M 10-K · filed 2026-02-24 | |
| 2023-01-01 | $326.44M 10-K · filed 2025-02-25 | |
| 2022-01-02 | $547.71M 10-K · filed 2024-02-27 | $562.70M 10-K · filed 2022-03-03 |
| 2021-01-03 | $210.13M 10-K · filed 2023-03-01 | $183.45M 10-K · filed 2021-03-02 |
| 2019-12-29 | $29.25M 10-K · filed 2022-03-03 | |
| 2018-12-30 | $32.63M 10-K · filed 2021-03-02 | |
| 2017-12-31 | $3.74M 10-K · filed 2020-02-25 | |
| 2017-01-01 | $39.69M 10-K · filed 2019-02-26 | |
| 2016-01-03 | -$21.51M 10-K · filed 2018-02-27 | $3.16M 10-K · filed 2016-03-01 |
| 2014-12-28 | -$58.89M 10-K · filed 2017-02-28 | -$37.76M 10-K · filed 2015-02-24 |
| 2013-12-29 | -$71.90M 10-K · filed 2016-03-01 | -$82.25M 10-K · filed 2014-02-25 |
| 2012-12-30 | -$113.97M 10-K · filed 2015-02-24 | -$118.55M 10-K · filed 2013-02-26 |
| 2012-01-01 | -$145.30M 10-K · filed 2014-02-25 | |
| 2011-01-02 | -$22.01M 10-K · filed 2013-02-26 | |
| 2010-01-03 | -$38.57M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |